CXCR家族蛋白在不同乳腺癌亚型中的表达及临床预后分析

doi:10.11904/j.issn.1002-3070.2019.03.003

Abstract

Abstract: Objective The aims of this study were to determine the expression of CXCR family proteins in various subtypes and adjacent tissues of breast cancer and its relationship with prognosis,and to provide a reference for clinical diagnosis,treatment and prognosis of breast cancer.Methods The mRNA expressive profiles of CXCR family proteins in paracancerous tissues and different subtypes of breast cancer tissues were obtained from the TCGA(The Cancer Genome Atlas)database.The prognostic survival analysis of each differentially expressed protein was obtained using the PRECOG website.Results Except for CXCR1,the expression of CXCR family proteins in breast cancer tissues and adjacent tissues was statistically different(P＜0.05).CXCR2P1,CXCR3,CXCR4,CXCR5 and CXCR6 were highly expressed in breast cancer tissues,CXCR2 and CXCR7 were lowly expressed in breast cancer tissues.The expressive levels of CXCR3,CXCR4 and CXCR7 were associated with the prognosis of patients.Conclusion The expressions of CXCR3,CXCR4 and CXCR7 in breast cancer tissues and adjacent tissues is significantly different,and its expression is related to the prognosis of breast cancer patients,which may be a potential target for molecular diagnosis or targeted therapy of breast cancer.

Key words: CXCR family proteins, Breast cancer, TCGA, Prognosis

CLC Number:

R737.9
R34

WANG Xiaoya,XIAO Bin,LIAO Yang,TANG Rongzhi,SUN Zhaohui,LI Linhai. Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis[J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 206-210.

References 1

Fan L,Strasser-weippl K,Li JJ,et al.Breast cancer in China[J].Lancet Oncol,2014,15(7):279-289.2 李林,李志高.二甲双胍与不同分子亚型乳腺癌的关系[J].实用肿瘤学杂志,2018,32(3):267-270.3 Pan XB,Chen RJ,Huang ST,et al.Systematic review and meta-analysis of the efficacy of breast conservation therapy followed by radiotherapy in four breast cancer subtypes[J].Oncotarget,2017,8(34):57414-57420.4 Battisti N,Okonji D,Manickavasagar T,et al.Outcomes of systemic therapy for advanced triple-negative breast cancer:A single centre experience[J].Breast,2018,40:60-66.5 郑正荣,杨春康,戴起宝.趋化因子受体对肿瘤生物学行为的影响[J].世界华人消化杂志,2006,14(5):513-518.6 韩堃,黎燕,陈国江.趋化因子及其受体在肿瘤转移中作用的研究进展[J].国际药学研究杂志,2012,39(5):386-390.7 Han X.Constitutively active chemokine CXC receptors[J].Adv Pharmacol,2014,70:265-301.8 Keane MP,Belperio JA,Xue YY,et al.Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer[J].J Immunol,2004,172(5):2853-2860.9 Zeng Y,Wang X,Yin B,et al.Role of the stromal cell derived factor-1/CXC chemokine receptor 4 axis in the invasion and metastasis of lung cancer and mechanism[J].J Thorac Dis,2017,9(12):4947-4959.10 Choi YJ,Chang WJ,Shin SW,et al.The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer[J].Onco Targets Ther,2016,9:3307-3312.11 Guo ZJ,Yang L,Qian F,et al.Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer[J].Oncotarget,2016,7(15):20999-21012.12 Yates TJ,Knapp J,Gosalbez M,et al.C-X-C chemokine receptor 7:a functionally associated molecular marker for bladder cancer[J].Cancer,2013,119(1):61-71.13 Richardsen E,Ness N,Melbo-jorgensen C,et al.The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer[J].Am J Pathol,2015,185(10):2722-2730.14 Miller LD,Smeds J,George J,et al.An expression signature for p53 status in human breast cancer predicts mutation status,transcriptional effects,and patient survival[J].Proc Natl Acad Sci U S A,2005,102(38):13550-13555.15 Ding Q,Xia Y,Ding S,et al.An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9[J].Oncotarget,2016,7(12):14405-14444.16 Li L,Chen J,Lu ZH,et al.Significance of chemokine receptor CXCR3 expression in breast cancer[J].Zhonghua Bing Li Xue Za Zhi,2011,40(2):85-88.17 Bronger H,Karge A,Dreyer T,et al.Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cells[J].Oncol Lett,2017,13(6):4224-4230.18 Huang MB,Giesler KE,Katzman BM,et al.Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells[J].Oncotarget,2018,9(24):16996-17013.19 Tulotta C,Stefanescu C,Beletkaia E,et al.Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model[J].Dis Model Mech,2016,9(2):141-153.20 Xiao G,Wang X,Wang J,et al.CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms[J].Oncotarget,2015,6(16):14165-14178.21 Cheng H,Chen NY.Expression of Chemokine receptor CXCR6 and its significance in breast cancer cell lines[J].Sichuan Da Xue Xue Bao Yi Xue Ban,2014,45(3):405-409.

[1]	LI Shuo,ZHANG Nannan,LI Liangliang,LONG Zhiping,YIN Huihui,ZHAO Yashuang,WANG Fan. Relationship between PDE4C gene methylation in peripheral blood leukocytes,interaction of environmental factors and pathogenesis of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 233-238.
[2]	FENG Yue,XING Linan,WANG Zhao,ZHANG Yunyan. Correlation between NLR and prognosis of concurrent chemoradiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 284-288.
[3]	CHEN Yanbo, KONG Dejia, ZHANG Jinfeng, MA Zhigang. Correlation between CYP2D6 gene polymorphism and tamoxifen metabolism in breast cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 110-114.
[4]	BAI Xiaobin, HUO Longwei, XIE Wanfu, XU Gaofeng, WANG Maode. Expression of Chk1 in glioblastoma and its association with tumor biological behavior and prognosis survival [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 122-127.
[5]	SHI Xiaokang, DING Youming, WANG Bin, YU Bin, XU Yu. Expression and clinical significance of UBE2T in primary liver cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 128-133.
[6]	SUN Jianghong, HAO Mingzhu, JIANG Dan, GUO Fei, LI Xiaomei. FFDM differential diagnosis of mastitis,benign hyperplasia and breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 139-141.
[7]	MA Zhijie, WANG Fan, ZHAO Yashuang. Analysis of life quality and influencing factors in breast cancer patients with chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 149-154.
[8]	LU Jiaoyun, ZHANG Qingyuan. Advances in laboratory markers in the prognosis of diffuse large B-cell lymphoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 183-187.
[9]	ZHAO Fengjuan, WANG Qi, REN Yunhong, WEI Jueling, LI Lequn, ZHAO Xinhua, TANG Juan, YOU Xuemei. Changes of serum CRP and hs-CRP levels in patients with liver cancer and depression and their influence on prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 27-33.
[10]	ZHANG Fengchun, JIANG Ying, LIU Zhaonan, YAN Ningning, CUI Hongquan, XU Yingchun. Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indicators in gastric cancer patients after radical resection [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 34-39.
[11]	MA Jianli, ZHANG Minghui, JI Hongfei, XU Xiangying. Clinical significance of combined detection of PD-L1 protein and CD8⁺TILs in resected lung adenocarcinoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 40-46.
[12]	MA Zhingying, SHANG Naijian, CAI Miaotian, SHEN Yang, JIANG Zhiyun. Correlation between HER-2 receptor of progesterone and estrogen receptor-positive breast cancer and mammography imaging & clinicopathological features [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 47-51.
[13]	YANG Hongbo, SHI Jie, YE Yong, LI Wencheng, DENG Zhaoping. Expression of COL5A2 in bladder cancer tissues and its correlation with clinicopathological features and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 52-56.
[14]	WANG Yalong, LYU Zhangyan, ZHANG Fan, FENG Xiaoshuang, WEI Luopei, LI Xin, WEN Yan, GAO Yushun, XUE Qi, GAO Shugeng, TAN Fengwei. Relationship between human papillomavirus infection and prognosis of lung cancer:A meta-analysis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 520-526.
[15]	TANG Shuli, HE Kuangbang, ZHANG Chunhui, CHENG Jianan, ZHANG Yanqiao. Expression of miR-320a and CYLD in gastric cancer and its relationship with clinicopathological characteristics and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 538-544.

Expression of CXCR family proteins in different subtypes of breast cancer and their clinical prognosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 1

Related Articles 15

Recommended Articles

Metrics

Comments